Amersham plc Annual Report & Accounts 2001: Board of Directors

Answering life's questions - Annual Report & Accounts 2001

1. Mr Richard D Lapthorne CBE, Bcom, FCMA, FCCA, FCT, CBIM Non-Executive Chairman ¹²³ Became Chairman of the Board in 1999. A board member since 1988, when he joined Amersham International plc as a Non-Executive Director. Recruited as Finance Director of British Aerospace plc in July 1992, becoming Vice Chairman in April 1998. Retired from British Aerospace at the end of September 1999. Also serves as Non-Executive Chairman of Morse plc, Avecia Ltd, Tunstall Holdings Limited, TI Automotive Limited and a Non-Executive Director of Oasis International Leasing in Abu Dhabi and Orange plc. Age 58.		2. Mr Johan Fr Odfjell Siv.øk., MBA Non-Executive Deputy Chairman ¹²³ Became Deputy Chairman of the Board in 1999. Was Chairman of the Board from 1997 to1999 and a non-executive board member of Nycomed ASA since 1996. Was Chief Executive of Vesta Insurance Group from 1986 to 1994 and from 1994 combined his own consultancy and investment firm with several non-executive board positions. Also serves as Chairman of Nera plc, Star Shipping plc, Norges Handels og Sjøfartstidende plc, Co-Chairman of Det Norske Veritas, and is a board member of Bergesen plc. Age 53.
03 Mr Donald H Brydon OBE, BSc Non-Executive Director ¹²³ Chairman Designate A Non-Executive Director since 1997 and will succeed Richard Lapthorne as Chairman following the Annual General Meeting in May 2003. Joined AXA Group in 1997 after a 20-year career with the Barclays Group. Now serving as Chairman of AXA Investment Managers, and a non-executive director of Allied Domecq and Chairman of the Financial Services Practitioner Panel. Age 57.		04 Mr George Battersby BSc Human Resources Director Joined the company in 2000 as Human Resources Director. Previously with Laporte plc from 1996 to 2000 as Human Resources Director, and Fisons plc from 1985 to 1996 as Group Human Resources Director. Earlier career included sales and marketing, consulting and human resources appointments in companies including International Computers Limited and Air Products and Chemicals Inc. Age 56.
05 Dr Andrew Carr Ph.D President, Amersham Biosciences Joined the company in 1987 as Senior Development Scientist and has held a number of senior management positions in research and development, manufacturing, and sales and marketing. Appointed President of Amersham Biosciences in 2000 and joined the Board in May 2002. Age 43.		06 Sir William Castell BA, FCA Chief Executive Chief Executive since1989,when he joined Amersham International plc. Previously Commercial Director Wellcome plc 1987-1989, following a career in Wellcome spanning over twentyy ears. Also serves as Chairman of The Prince’s Trust and Council Member of the Medical Research Council, and is on the External Advisory Board for the Life Sciences Institute at Michigan. Knighted in June 2000 for services to the life sciences industry. Age 55.
7. Mr Giles F B Kerr BA, ACA Finance Director Appointed Finance Director in 1997. Joined Amersham International plc as Group Financial Controller (1991-1994), Commercial Controller (1994-1996), Company Secretary and Director of Corporate Development (1996-1997). Worked for Arthur Andersen & Co from 1981, in positions including Audit and Accounting Manager and Partner, Corporate Finance and Investigations. Age 42.		8. Dr John M Padfield BPharm, PhD, FRPharmS, FRSC Chief Executive, Amersham Health Joined the company in 1999 as Chief Executive of Nycomed Amersham Imaging (now Amersham Health). Was Chief Executive of Chiroscience plc from 1994 to 1999 and for 15 years prior to this held board positions in several subsidiary companies at Glaxo. Appointed to the Biotechnology and Biological Sciences Research Council in 1998, also served as a Director of The BioIndustry Association and was appointed to the Board of Intrabiotics Pharmaceuticals Inc in 1998. Age 55.
9. Dr John S Patterson FRCP Non-Executive Director ¹² A Non-Executive Director since 2001. Has had a long career with ICI Pharmaceuticals and was appointed Vice President for Clinical Research and Medical Affairs in the USA in 1988. In 1990 joined its board as Medical Director. Was appointed Executive Vice President Product Strategy and Licensing for AstraZeneca in 1999 and currently serves as Chair on its Portfolio Management and Licensing Executive Sub-Committees. Also serves as a Director of the British Pharmaceuticals Group and is President-Elect of ABPI (Association of the British Pharmaceutical Industry). Age 54.		10. Sir Keith Peters MB BCh, FRCP, FRCPath, FRS Non-Executive Director A Non-Executive Director since 2000. He is also Chairman of the Amersham plc Scientific Advisory Board. Regius Professor of Physic at the University of Cambridge since 1987; Honorary Consultant Physician at Addenbroke’s NHS Trust; Chairman of the British Heart Foundation; member of Council of Heads of Medical Schools and Deans of UK Faculties of Medicine; Chairman PPP Foundation;Governing Trustee, The Nuffield Trust; Trustee, Strangeways Research Laboratory; member of Scientific Advisory Boards of the Gairdner Foundation and Merck Institute. Age 64.
11. Mr Jacques F Rejeange MBA Non-Executive Director ¹²³ A Non-Executive Director since 1997, having been a non-executive board member of Hafslund Nycomed ASA since 1994. From 1966 to 1992 was employed by the Sandoz Group, rising from Management Trainee to President and Chief Executive of Sandoz Pharmaceuticals Inc in the USA. Became President and Chief Executive of Sterling Winthrop Inc in 1994 and in 1998 was appointed Chief Executive of NMT Management AG. Is also a Non-Executive Director of Antares Inc and Pozen Inc, both in the USA. Age 62.		12. Professor Erik Thorsby MD Non-Executive Director ¹² A Non-Executive Director since 1997, having earlier that year joined the Nycomed ASA board as a non-executive member. Has held a number of positions in medical institutions, international scientific societies and committees and in 1983 was appointed Professor of Medicine at the University of Oslo. He is Head of the Institute of Immunology at The National Hospital and University of Oslo. Also serves as President of the European Federation for Immunogenetics and is Chairman of the Research Council at The National Hospital. Age 63.
1 Members of the Remuneration Committee, which is chaired by Mr Richard D Lapthorne. 2 Members of the Nomination Committee, which is chaired by Mr Johan Fr Odfjell. 3 Members of the Audit Committee, which is chaired by Mr Donald H Brydon.